Surveillance of Transmitted Drug-Resistant HIV Among Young Pregnant Women in Ouagadougou, Burkina Faso

Antoine Somda; Lassana Sangare; Monique Soro; Saydou Yameogo; Babou Bazie; Françoise Bigirimana; Silvia Bertagnolio; Martine Peeters; Fatima Mouacha; Ana Maria Rivera; Michael R. Jordan; Marie-Joseph Sanou

doi:10.1093/cid/cir988

Retour

Surveillance of Transmitted Drug-Resistant HIV Among Young Pregnant Women in Ouagadougou, Burkina Faso

Article de revue

Avec comité de lecture

Surveillance of Transmitted Drug-Resistant HIV Among Young Pregnant Women in Ouagadougou, Burkina Faso

Antoine Somda, Lassana Sangare, Monique Soro, Saydou Yameogo, Babou Bazie, Françoise Bigirimana, Silvia Bertagnolio, Martine Peeters, Fatima Mouacha, Ana Maria Rivera, …

Clinical infectious diseases, Vol.54(Suppl 4), pp.S317-S319

15/05/2012

DOI: https://doi.org/10.1093/cid/cir988

PMID: 22544195

Résumé

Supplement

Burkina Faso began rapid antiretroviral therapy (ART) scale-up in 2003 and by December 2009, 26 448 individuals were on treatment. With rapid scale-up of ART, some degree of human immunodeficiency virus transmitted drug resistance (TDR) is inevitable. Following World Health Organization methods, between June 2008 and July 2009, Burkina Faso assessed TDR in primigravid pregnant women aged <25 years attending antenatal care clinics in Ouagadougou, Burkina Faso. TDR was classified as moderate (5%–15%) for both nucleoside reverse-transcriptase inhibitors and nonnucleoside reverse-transcriptase inhibitors. The observed moderate TDR in Ouagadougou is a cause for concern and calls for closer monitoring of Burkina Faso's ART program.

Indicateurs

1 Consultations de la notice

Détails

Titre: Surveillance of Transmitted Drug-Resistant HIV Among Young Pregnant Women in Ouagadougou, Burkina Faso
Créateurs - sans rôle: Antoine Somda - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Lassana Sangare - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Monique Soro - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Saydou Yameogo - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Babou Bazie - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Françoise Bigirimana - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Silvia Bertagnolio - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Martine Peeters - Université de Montpellier
Fatima Mouacha - Université de Montpellier
Ana Maria Rivera - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Michael R. Jordan - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Marie-Joseph Sanou - Ministry of Health/BFA, HIV Surveillance Ministry of Health–LNR HIV World Health Organization, Ouagadougou, Burkina Faso World Health Organization, Geneva, Switzerland UMI233, Institut de Recherche pour le Development and Université de Montpellier 1, France Tufts University School of Medicine, Boston, Massachusetts
Détails de publication: Clinical infectious diseases, Vol.54(Suppl 4), pp.S317-S319
Éditeur: Oxford University Press
Identifiants: 99158666009311
Unité académique: Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
Langue: English
Type de ressource: Journal article